Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Firm strength in dollar offsets gains in INR made from positive equities and easing oil prices
The Indian rupee depreciated 34 paise to close at 94.67 (provisional) against the US dollar on Monday, weighed down by the strength of the American currency in the overseas market. Rupee witnessed volatility as steady debt and deposit inflows pulled the domestic currency in one way, while the lack of clarity on the Middle East peace deal and a firm dollar pulled it the other way. The Indian stock market, which snapped a five-day winning streak on Friday, rebounded and closed higher on Monday, lifted by gains in technology, healthcare and oil sectors. The mood in the market remained positive amid reports of progress in US-Iran peace talks. Additionally, weak oil prices eased concerns about inflation. The benchmark BSE Sensex closed up by 291.17 points or 0.38% at 77,094.07 after scaling a low of 77,160.67 and a high of 77,325.56 intraday. At the interbank foreign exchange market, the rupee opened at 94.42, registering a decline of 9 paise from its previous close. In intraday trade, ...
Sensex Today | Stock Market LIVE Updates: Nifty, Sensex set for muted open; Anthem Biosciences in focus
Sensex Today | Stock Market LIVE Updates:Today is the weekly expiry of all BSE contracts. The recent phase for the market has been a good one, with the Nifty having recovered 1,000 points from last week's low of 23,070. A close above 24,000 is also a positive.
HDFC MF, ADIA among buyers as Sepia Investments offloads Rs 749 crore in Corona Remedies via block deal
Sepia Investments and Anchor Partners sold shares worth about Rs 777 crore in Corona Remedies through block deals. HDFC Mutual Fund emerged as the largest buyer, while several institutional investors, including Aberdeen entities, ADIA, Invesco and WhiteOak, also accumulated stakes.
KIMS launches ₹1,500 crore QIP to repay debt and fund subsidiaries
KIMS has launched a ₹1,500 crore qualified institutions placement (QIP) through a 100% primary share issuance, with the indicative price set at ₹755 per share at up to a 3% discount to the last closing price. The hospital chain plans to use the proceeds to repay debt and fund investments in its subsidiaries, with the issue expected to be priced later this week and listed on the NSE and BSE thereafter.
Oil prices to ease after US-Iran deal, but return to pre-war levels could take months: Analysts
Energy markets anticipate price moderation for crude oil and liquefied natural gas. A potential US-Iran peace agreement and the reopening of the Strait of Hormuz are key factors. However, analysts warn of continued volatility due to supply disruptions and low inventories. India's energy security and import costs are expected to improve. Full market normalisation may take months.
Nifty tops 23,850 as oil slump sparks broad-based rally
The key equity benchmark indices extended gains for a second consecutive session on Monday, supported by a sharp decline in crude oil prices and optimism surrounding a US-Iran peace agreement. Buying was broad-based, with most sectoral indices ending in the green. Investor sentiment was further buoyed by strong global cues, a stronger rupee and easing market volatility. The Nifty settled above the 23,850 mark, led by gains in consumer durables and auto stocks. However, pharma and healthcare shares bucked the trend and closed lower.
Stocks in news: Dr Reddy’s, Adani Green, KIMS, JSW Energy, Nestle India
Markets saw a strong rebound on Friday, driven by positive global cues and easing geopolitical tensions. Nifty defended the 23,000 support and reclaimed 23,500, with potential for further gains. Several stocks like Dr Reddy's, Adani Green, and JSW Energy are in focus due to significant corporate developments.
Indian Stock Market Weekly Wrap: Can Sensex & Nifty Hold the 2% Rally, or Is Volatility About to Take Over? What Investors Should Know Before Monday Opening - The Sunday Guardian
Indian Stock Market Weekly Wrap: Can Sensex & Nifty Hold the 2% Rally, or Is Volatility About to Take Over? What Investors Should Know Before Monday OpeningThe Sunday Guardian
Sensex Today | Stock Market LIVE Updates: GIFT Nifty extends losses, falls 170 points; Brent above $94
Sensex Today | Stock Market LIVE Updates: Today is the weekly expiry of all Sensex contracts. For the Nifty, the recent lows of 23,070 come into play again after the breakout sold off between 23,450 - 23,500 levels, which remains the key resistance on the upside. Analysts maintain that any drop below the 23,070 low could take the index down to 22,800 - 22,700 levels.
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.
Sebi may widen 50% overlap rule to thematic passive mutual fund schemes
Curb on number of smart-beta schemes also likely; move aimed at curbing proliferation in segment
Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.